Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Leveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.
Learn More
Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.
Learn More
Hospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.
Learn MoreA specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.
Learn More
Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.
Learn More
Health benefit analytics for effective response to market changes.
Learn More
Take your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.
Learn MoreExplore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.
Learn MoreMedia representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.
Learn More
Artificial intelligence and machine learning have been adopted by those in life sciences needing access to deeper market insights to craft real world data-driven strategies with speed and precision.
Life science companies can reap the benefits of these technologies by partnering with IQVIA and leveraging our life sciences specific infrastructure and resources.
Everyone is at a different point in utilizing AI/ML to generate insights. Those still wondering whether they should add AI/ML to their commercial toolkit should read Beyond Classical Statistics: What Machine Learning Offers Life Sciences Industry. This insightful blog compares Classical Statistics and Machine Learning, weighing the challenges and benefit of each approach.
For those interested in how AI/ML can be applied on their clinical decision making, read our case studies Using AI/ML to generate real world evidence and Leveraging AI/ML for Predictive Segmentation. In the first article, our Real World Solutions (RWS) team explains how using artificial intelligence and machine learning help in disease prevalence and rare disease detection. In the second article, our Commercial Effectiveness Services (CES) team explains how one commercial application of AI/ML is used to predict key patient and physician segments in order to advance treatments and improve outcomes.
At IQVIA, we believe that there can be different approaches to a solution along with some best practices based on data, technology, and our expertise in the life science industry. Read Making AI/ML Part of Daily Decision Making where our Technology Solutions team talks about where to begin an AI/ML initiative, the top challenges and considerations to help companies accelerate adoption.
